After months spent pursuing a plan to convert itself into a for-profit business, OpenAI is reversing course and said Monday ...

Positive Lexeo Therapeutics, Inc. interim data from SUNRISE-FA study highlights LX2006's potential for Friedreich's Ataxia.

Tim Friede has been bitten by hundreds of snakes. And now, scientists are studying his blood to create a universal antivenom.

Wegovy and Zepbound, the two leading weight-loss drugs, together sold less than $5 billion in 2023, according to ...

Explore the latest NSCLC new treatments in development, including candidates aimed at tackling hard-to-treat, late-stage lung ...

Protein Engineering Market IntroductionThe protein engineering market is rapidly evolving, driven by the need to develop proteins with improved functionality for a range of applications, including ...

Rezolute has done well to continue to advance its lead drug from its pipeline, ersodetug. Click here to see why RZLT stock is ...

NIH program to make vaccines against pathogens that can trigger pandemics uses approach pioneered in last century ...

However, in March, after settling a $30 million lawsuit over a data breach, 23andMe declared bankruptcy and announced they ...

Ace Infoway Private Limited, a wholly owned subsidiary of Ace Software Exports Limited has received a contract for the development of the EV Charging Application and Kisok Interface Application from a ...

In recognition of ALS Awareness Month this May, Target ALS is proud to launch Behind Every Breakthrough—a month-long ...

Japan continues to pace like-minded governments when making economic security policy. Successive administrations in Tokyo ...